Latest American Society for Radiation Oncology Stories
A new study shows that a new type of targeted radiation therapy called stereotactic radiation therapy is just as good as surgery for patients aged 75 and older with early-stage lung cancer.
Ipilimumab used in combination with paclitaxel/carboplatin for stage IIIb/IV non-small cell lung cancer showed superior results in progression free survival when compared to paclitaxel/carboplatin alone.
A new study shows that a combination of epigenetic therapy and molecular targeted therapy has promising results at combating advanced lung cancer.
New data shows that people exposed to the mineral erionite found in the gravel of road materials in North Dakota may be at significantly increased risk of developing mesothelioma, a type of lung cancer most often associated with asbestos exposure.
Cancer researchers have identified six gene markers present in early stage non-small cell lung cancer (NSCLC) that show promise in helping oncologists better identify which tumors will relapse after curative surgery.
SAN DIEGO, Nov.
SUNNYVALE, Calif., Oct.
SAN DIEGO, Oct. 28 /PRNewswire/ - At the American Society for Radiation Oncology (ASTRO) 52nd Annual Meeting, October 31-November 4 in San Diego, Elekta (booth # 913) will showcase its comprehensive range of advanced solutions for managing cancer safely and effectively.
Stereotactic radiation is an effective, long-term treatment for trigeminal neuralgia: a painful condition that occurs with increased frequency in patients with multiple sclerosis (MS).
Adding chemotherapy to radiation therapy for muscle invasive bladder cancer allows 67 percent of people to be free of disease in their bladders two years after treatment.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.